Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Pain Management in Cardiac Implantable Electronic Device Insertion; Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05575999

Organisation Name: Kansas City Heart Rhythm Research Foundation

Overal Status: Not yet recruiting

Start Date: January 2023

Last Update: November 16, 2022

Lead Sponsor: Kansas City Heart Rhythm Research Foundation

Brief Summary: Bupivacaine is the most widely used local anesthetic agent across majority of the Cardiac Implantable Electronic device (CIED) implant procedures in the United States. It is hypothesized that the combination of Bupivacaine-Ketorolac-Ketamine (BKK) is more effective in alleviating perioperative and postoperative pain as compared to the use of bupivacaine alone.

A few studies have been done to look for the effectiveness of BKK in abdominal surgical procedures. However, no study has been done to evaluate its efficacy and effectiveness in patients undergoing CIED insertion.

Conditions:
  • Pain Management


Total execution time in seconds: 0.21043395996094